Effects of doxorubicin on cardiac muscle subsarcolemmal and intermyofibrillar mitochondria

Adhihetty, 2005, Differential susceptibility of subsarcolemmal and intermyofibrillar mitochondria to apoptotic stimuli, Am. J. Physiol. Cell Physiol., 289, C994, 10.1152/ajpcell.00031.2005 Adhihetty, 2007, Effect of denervation on mitochondrially mediated apoptosis in skeletal muscle, J. Appl. Physiol., 102, 1143, 10.1152/japplphysiol.00768.2006 Ascensao, 2005, Endurance training attenuates doxorubicin-induced cardiac oxidative damage in mice, Int. J. Cardiol., 100, 451, 10.1016/j.ijcard.2004.11.004 Ascensao, 2005, Moderate endurance training prevents doxorubicin-induced in vivo mitochondriopathy and reduces the development of cardiac apoptosis, Am. J. Physiol. Heart Circ. Physiol., 289, H722, 10.1152/ajpheart.01249.2004 Ascensao, 2006, Effects of endurance training and acute doxorubicin treatment on rat heart mitochondrial alterations induced by in vitro anoxia-reoxygenation, Cardiovasc. Toxicol., 6, 159, 10.1385/CT:6:3:159 Chabi, 2008, Mitochondrial function and apoptotic susceptibility in aging skeletal muscle, Aging Cell, 7, 2, 10.1111/j.1474-9726.2007.00347.x Chicco, 2005, Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart, Am. J. Physiol. Regul. Integr. Comp. Physiol., 289, R424, 10.1152/ajpregu.00636.2004 Chicco, 2006, Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity, J. Appl. Physiol., 100, 519, 10.1152/japplphysiol.00148.2005 Chicco, 2006, Exercise training attenuates acute doxorubicin-induced cardiac dysfunction, J. Cardiovasc. Pharmacol., 47, 182, 10.1097/01.fjc.0000199682.43448.2d Childs, 2002, Doxorubicin treatment in vivo causes cytochrome C release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio, Cancer Res., 62, 4592 Cogswell, 1993, Properties of skeletal muscle mitochondria isolated from subsarcolemmal and intermyofibrillar regions, Am. J. Phys., 264, C383, 10.1152/ajpcell.1993.264.2.C383 Dirks-Naylor, 2013, The role of autophagy in doxorubicin-induced cardiotoxicity, Life Sci., 10.1016/j.lfs.2013.10.013 Dirks-Naylor, 2014, Doxorubicin alters the mitochondrial dynamics machinery and mitophagy in the liver of treated animals, Fundam. Clin. Pharmacol., 28, 633, 10.1111/fcp.12073 Doroshow, 1985, Ultrastructural features of Adriamycin-induced skeletal and cardiac muscle toxicity, Am. J. Pathol., 118, 288 Green, 2002, Mitochondrial dysfunction is an early indicator of doxorubicin-induced apoptosis, Biochim. Biophys. Acta, 1588, 94, 10.1016/S0925-4439(02)00144-8 Iarussi, 2001, Recent advances in the prevention of anthracycline cardiotoxicity in childhood, Curr. Med. Chem., 8, 1649, 10.2174/0929867013371888 Iqbal, 2015, The role of mitochondrial fusion and fission in skeletal muscle function and dysfunction, Front. Biol. (Landmark Ed), 20, 157, 10.2741/4303 Jang, 2004, Doxorubicin treatment in vivo activates caspase-12 mediated cardiac apoptosis in both male and female rats, FEBS Lett., 577, 483, 10.1016/j.febslet.2004.10.053 Jeyaseelan, 1997, Molecular mechanisms of doxorubicin-induced cardiomyopathy. Selective suppression of Reiske iron-sulfur protein, ADP/ATP translocase, and phosphofructokinase genes is associated with ATP depletion in rat cardiomyocytes, J. Biol. Chem., 272, 5828, 10.1074/jbc.272.9.5828 Jung, 2001, Mitochondria as subcellular targets for clinically useful anthracyclines, Adv. Drug Deliv. Rev., 49, 87, 10.1016/S0169-409X(01)00128-4 Kang, 1997, Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity, J. Clin. Invest., 100, 1501, 10.1172/JCI119672 Kavazis, 2008, Exercise induces a cardiac mitochondrial phenotype that resists apoptotic stimuli, Am. J. Physiol. Heart Circ. Physiol., 294, H928, 10.1152/ajpheart.01231.2007 Kavazis, 2009, Exercise training induces a cardioprotective phenotype and alterations in cardiac subsarcolemmal and intermyofibrillar mitochondrial proteins, Am. J. Physiol. Heart Circ. Physiol. U.S., H144, 10.1152/ajpheart.01278.2008 Kavazis, 2009, Exercise training induces a cardioprotective phenotype and alterations in cardiac subsarcolemmal and intermyofibrillar mitochondrial proteins, Am. J. Physiol. Heart Circ. Physiol., 297, H144, 10.1152/ajpheart.01278.2008 Kavazis, 2009, Mechanical ventilation induces diaphragmatic mitochondrial dysfunction and increased oxidant production, Free Radic. Biol. Med., 46, 842, 10.1016/j.freeradbiomed.2009.01.002 Kavazis, 2010, Short-term exercise training protects against doxorubicin-induced cardiac mitochondrial damage independent of HSP72, Am. J. Physiol. Heart Circ. Physiol., 299, H1515, 10.1152/ajpheart.00585.2010 Lu, 2005, Monitoring cardiac function in patients receiving doxorubicin, Semin. Nucl. Med., 35, 197, 10.1053/j.semnuclmed.2005.02.005 Min, 2015, Increased mitochondrial emission of reactive oxygen species and calpain activation are required for doxorubicin-induced cardiac and skeletal muscle myopathy, J. Physiol., 593, 2017, 10.1113/jphysiol.2014.286518 Narendra, 2011, Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control, Antioxid. Redox Signal., 14, 1929, 10.1089/ars.2010.3799 Neilan, 2007, Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin, Circulation, 116, 506, 10.1161/CIRCULATIONAHA.106.652339 Olichon, 2003, Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis, J. Biol. Chem., 278, 7743, 10.1074/jbc.C200677200 Palmer, 1977, Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle, J. Biol. Chem., 252, 8731, 10.1016/S0021-9258(19)75283-1 Piantadosi, 2008, Heme oxygenase-1 regulates cardiac mitochondrial biogenesis via Nrf2-mediated transcriptional control of nuclear respiratory factor-1, Circ. Res., 103, 1232, 10.1161/01.RES.0000338597.71702.ad Powers, 2012, Mitochondrial signaling contributes to disuse muscle atrophy, Am. J. Physiol. Endocrinol. Metab., 303, E31, 10.1152/ajpendo.00609.2011 Romanello, 2010, Mitochondrial biogenesis and fragmentation as regulators of muscle protein degradation, Curr. Hypertens. Rep., 12, 433, 10.1007/s11906-010-0157-8 Romanello, 2010, Mitochondrial fission and remodelling contributes to muscle atrophy, EMBO J., 29, 1774, 10.1038/emboj.2010.60 Rosca, 2010, Mitochondria in heart failure, Cardiovasc. Res., 88, 40, 10.1093/cvr/cvq240 Sandri, 2013, Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome, Int. J. Biochem. Cell Biol., 45, 2121, 10.1016/j.biocel.2013.04.023 Singal, 2000, Adriamycin-induced heart failure: mechanism and modulation, Mol. Cell. Biochem., 207, 77, 10.1023/A:1007094214460 Smuder, 2011, Exercise protects against doxorubicin-induced markers of autophagy signaling in skeletal muscle, J. Appl. Physiol., 111, 1190, 10.1152/japplphysiol.00429.2011 Smuder, 2012, Endurance exercise attenuates ventilator-induced diaphragm dysfunction, J. Appl. Physiol., 112, 501, 10.1152/japplphysiol.01086.2011 Smuder, 2013, Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals, J. Appl. Physiol., 115, 176, 10.1152/japplphysiol.00924.2012 Smuder, 2013, Doxorubicin-induced markers of myocardial autophagic signaling in sedentary and exercise trained animals, J. Appl. Physiol., 115, 176, 10.1152/japplphysiol.00924.2012 Suliman, 2007, The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy, J. Clin. Invest., 117, 3730 Takahashi, 1996, Protein import into subsarcolemmal and intermyofibrillar skeletal muscle mitochondria. Differential import regulation in distinct subcellular regions, J. Biol. Chem., 271, 27285, 10.1074/jbc.271.44.27285 Vejpongsa, 2014, Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities, J. Am. Coll. Cardiol., 64, 938, 10.1016/j.jacc.2014.06.1167 Wallace, 2003, Doxorubicin-induced cardiac mitochondrionopathy, Pharmacol. Toxicol., 93, 105, 10.1034/j.1600-0773.2003.930301.x Walsh, 2006, Enhanced mitochondrial sensitivity to creatine in rats bred for high aerobic capacity, J. Appl. Physiol., 100, 1765, 10.1152/japplphysiol.01533.2005 Weinstein, 1986, Subpopulations of human heart mitochondria, J. Surg. Res., 40, 495, 10.1016/0022-4804(86)90221-0 Yen, 1996, The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice, J. Clin. Invest., 98, 1253, 10.1172/JCI118909 Youle, 2005, Mitochondrial fission in apoptosis, Nat. Rev. Mol. Cell Biol., 6, 657, 10.1038/nrm1697 Zhang, 2009, Cardiomyocyte death in doxorubicin-induced cardiotoxicity, Arch. Immunol. Ther. Exp., 57, 435, 10.1007/s00005-009-0051-8 Zhang, 2012, Identification of the molecular basis of doxorubicin-induced cardiotoxicity, Nat. Med., 18, 1639, 10.1038/nm.2919 Zhou, 2001, Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin, Cancer Res., 61, 771